Terms: = Prostate cancer AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758 AND Staging
3 results:
1. Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time.
Dhondt B; De Bleser E; Claeys T; Buelens S; Lumen N; Vandesompele J; Beckers A; Fonteyne V; Van der Eecken K; De Bruycker A; Paul J; Gramme P; Ost P
World J Urol; 2019 Dec; 37(12):2557-2564. PubMed ID: 30578441
[TBL] [Abstract] [Full Text] [Related]
2. Extent of extraprostatic extension independently influences biochemical recurrence-free survival: evidence for further pT3 subclassification.
Ball MW; Partin AW; Epstein JI
Urology; 2015 Jan; 85(1):161-4. PubMed ID: 25440818
[TBL] [Abstract] [Full Text] [Related]
3. GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.
Maldonado L; Brait M; Loyo M; Sullenberger L; Wang K; Peskoe SB; Rosenbaum E; Howard R; Toubaji A; Albadine R; Netto GJ; Hoque MO; Platz EA; Sidransky D
J Urol; 2014 Nov; 192(5):1542-8. PubMed ID: 24769028
[TBL] [Abstract] [Full Text] [Related]
